The advertising defined in article L. 5122-1 must not be misleading or undermine the protection of public health. It must present the medicinal product or product objectively and encourage its proper use.
It must comply with the provisions of the marketing authorisation and the therapeutic strategies recommended by the French National Authority for Health.